News

Mint Medical at RKR

Mint Medical at the Radiology Congress Ruhr (booth #44) The Radiology Congress Ruhr is a convention well-established amongst radiologists in Germany, which has advanced to be the second-largest radiological congress in German-speaking countries. This year the congress will take place in Bochum from October 13…

Distribution network

Mint Medical establishes international network of distribution partners As a consequence of numerous requests from foreign radiologists during the mint Lesion™ product launch at RSNA 2010, Mint Medical started to launch mint Lesion™ in overseas countries in joint efforts with local distribution partners. Meanwhile, more…

mint Lesion™ 1.4

mint Lesion™ 1.4 introduced at the 92nd German Radiology Congress At this year’s annual meeting of the German Radiological Society in Hamburg, Germany we launched mint Lesion™ 1.4, our solution for quantitative imaging in oncological radiology. Together with our partner CHILI GmbH, we demonstrated the…

mint Lesion™ in USZ

University Hospital Zurich, Switzerland, focuses on quality in quantitative imaging provided by mint Lesion™ The University Hospital Zurich counts on mint Lesion™ to conduct quantitative imaging. The Institute of Diagnostic and Interventional Radiology uses a Thin Client installation of mint Lesion™ to improve quality and…

Relocation of Mint Medical

Our offices had to extend with our team   Our offices had to grow with our team. The spacious offices of our new domicile create an organizational framework and the necessary room for a comfortable, cooperative working environment, for customers’ visits and for high-level user…

mint Lesion™ 1.6

Mint Medical releases mint Lesion™ 1.6 – a major step to facilitate an efficient assessment of tumor therapies mint Lesion™ 1.6 is the third feature release in 2011 – and so far our biggest improvement. Rigorously designed to meet contemporary clinical needs, mint Lesion™ 1.6…

Cooperation with SLK Heilbronn

R&D cooperation with SLK Clinics Heilbronn to optimize the assessment of HCC therapies Targeted therapy methods to treat hepatocellular carcinomas, such as chemoembolization (TACE) or internal radiation therapy (SIRT), are gaining importance in HCC treatment. In this context, criteria like RECIST or WHO provide only…